U.S. Markets closed

Economic gloom hits world stock markets

1 / 2

What's happening to global growth?

What's happening to global growth? (AFP Photo/Andrew Burton)

New York (AFP) - Worries about economic growth prospects hit global stock markets on Friday, causing sharp price drops on both sides of the Atlantic.

In bloodletting on Wall Street, US stocks suffered their worst day since early January.

The closely watched "yield curve" flashed a warning sign that a recession could be looming while monthly US, French and German manufacturing indices all fell -- rattling investors who were already uneasy after this week's surprisingly weak outlook from the Federal Reserve.

"A series of worse-than-expected economic releases from Europe have sounded the alarm bell not just for the bloc, but also the global economy, by providing further evidence of a worldwide slowdown in economic activity," said XTB analyst David Cheetham.

The so-called yield curve, which tracks the spread between short- and longer-term rates on US Treasury bonds, briefly inverted on Friday, with yields on three month bonds falling below those for 10-year notes -- the first time this had happened since before the global financial crisis in 2007.

The yield curve is closely watched since it has inverted prior to recessions in recent decades.

But Justin Lederer, interest rates strategist at Cantor Fitzgerald, told AFP the flip was not cause for so much alarm.

"The yield curve inversion reveals more what is going on in the global landscape, the fact that global growth is slowing down," he said.

"I don't think it is an immediate signal that a recession is approaching."

Also weighing on the benchmark Dow Jones Industrial Average were poor showings for Boeing and Nike, which fell 2.8 percent and 6.6 percent.

An Indonesian air carrier on Friday became the first to announce it was canceling a multi-billion-dollar order of 737 MAX aircraft in the wake of recent fatal crashes in which nearly 350 people perished.

In foreign exchange, sterling rose again after Brussels gave Britain a Brexit deadline extension.

Signs of a weak first quarter for the eurozone also mounted on Friday as a closely-watched survey pointed to March output being dragged further down by manufacturing weakness, especially in Germany, Europe's largest economy.

The German data were "shockingly bad", said Angel Talavera, an economist with Oxford Economics, and "a timely reminder that the European industrial sector continues to be dominated by worries and potential negative shocks, including the outcome of the Brexit negotiations, trade concerns and problems in the auto industry."

- Brexit endgame -

The pound however pushed higher one day after European Union leaders agreed at a crucial summit to delay Brexit following a request from Prime Minister Theresa May.

If the premier fails next week to push her divorce agreement through a fractious parliament that has already rejected the deal twice, Brexit will take place on April 12, unless London agrees to take part in European elections.

If May manages to get the deal passed, the exit date will be pushed back until May 22.

Britain had been due to crash out of the bloc next Friday.

"Sterling remains very volatile as EU leaders have moved to stop a chaotic no-deal Brexit from happening next week by handing Theresa May an extra fortnight," said Oanda analyst Craig Popplewell.

The world's main oil contracts also fell sharply, as a softer economy would likely lead to less demand for the fossil fuel.

- Key figures around 2130 GMT -

New York - DOW: DOWN 1.8 percent at 25,502.32 (close)

New York - S&P: DOWN 1.9 percent at 2,800.71(close)

New York - Nasdaq: DOWN 2.5 percent 7,642.67 (close)

London - FTSE 100: DOWN 2.0 percent at 7,207.59 points (close)

Frankfurt - DAX 30: DOWN 1.6 percent at 11,364.17 (close)

Paris - CAC 40: DOWN 2.0 percent at 5,269.92 (close)

EURO STOXX 50: DOWN 1.8 percent at 3,305.73 (close)

Pound/dollar: UP at $1.3210 from $1.3107 at 2100 GMT on Thursday

Euro/pound: DOWN at 85.59 pence from 86.77 pence

Euro/dollar: DOWN at $1.1306 from $1.1374

Dollar/yen: DOWN at 109.93 yen from 110.82 yen

Tokyo - Nikkei 225: UP 0.1 percent at 21,627.34 (close)

Hong Kong - Hang Seng: UP 0.1 percent at 29,113.36 (close)

Shanghai - Composite: UP 0.1 percent at 3,104.15 (close)

Oil - Brent Crude: DOWN 94 cents at $66.32 per barrel

Oil - West Texas Intermediate: DOWN 83 cents at $58.42


  • Business

    PepsiCo results beat as new CEO's ad push lifts sales

    PepsiCo Inc's quarterly sales and profit beat Wall Street estimates on Wednesday, as the beverage maker's advertising and marketing push helped drive sales of its snacks, sparkling waters and low-sugar sodas globally. Shares of PepsiCo hit a record high of $125.92 in morning trading after the company said its core sales grew at the fastest pace in more than three years. The results come as a boost for Chief Executive Officer Ramon Laguarta who took over from Indra Nooyi six months ago.

  • How M.D.C. Holdings, Inc. (NYSE:MDC) Can Impact Your Portfolio Volatility
    Simply Wall St.

    How M.D.C. Holdings, Inc. (NYSE:MDC) Can Impact Your Portfolio Volatility

    Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). While we should keep in mind that Warren Buffett has cautioned that 'Volatility is far from synonymous with risk', beta is still a useful factor to consider. To make good use of it you must first know that the beta of the overall market is one.

  • Here's Why StoneCo Stock Is Plunging Today
    Motley Fool

    Here's Why StoneCo Stock Is Plunging Today

    Shares of Brazilian fintech company StoneCo (NASDAQ: STNE), which gained notoriety in recent months after being added to Berkshire Hathaway's portfolio, are plummeting today. Generally speaking, moves like this are often seen after earnings announcements, but StoneCo isn't set to report earnings again for another couple months. In this case, the plunge appears to be triggered by a move from a rival company.

  • Business

    Be Careful With Healthcare Stocks Here

    That has been evident in this week's trading in healthcare stocks. The Healthcare Select SPDR has plummeted this week, trading today at $85.68 after reaching a level of $92 per share as recently as April 5th. The plunge in healthcare stocks can be attributed to three words uttered by UnitedHealth Group CEO David Wichmann on his company's earnings conference call Tuesday: "Medicare For All."

  • A Look At The Fair Value Of Nuance Communications, Inc. (NASDAQ:NUAN)
    Simply Wall St.

    A Look At The Fair Value Of Nuance Communications, Inc. (NASDAQ:NUAN)

    Does the April share price for Nuance Communications, Inc. (NASDAQ:NUAN) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting them to their present value. Remember though, that there are many ways to estimate a company's value, and a DCF is just one method.

  • Business
    Thomson Reuters StreetEvents

    Edited Transcript of SFBS earnings conference call or presentation 15-Apr-19 9:15pm GMT

    As most of you know, typically the first quarter is not the best quarter of our year for ServisFirst, and -- but we're very pleased with the solid growth that we did have in the first quarter, which is above average for our company over the last several years. On the deposit side, we had annualized deposit growth for the quarter of 10% and it was very broad-based, with Atlanta, Tampa, Mobile, Huntsville and Pensacola having the best growth. Typically, in the first quarter, we have very little, if any, deposit growth.

  • Business

    GE Stock Got a Thumbs Up From a Mysterious 'Smartest Man'

    GE)'s beaten-down stock is up 25% year to date, and Melius Research analyst Scott Davis says the smartest industrial investor he knows is buying the shares. That's a tantalizing statement. Who is this investing star?

  • Canopy Growth strikes $3.4B deal to buy Acreage
    Yahoo Finance Video

    Canopy Growth strikes $3.4B deal to buy Acreage

    Canopy Growth stock is up today on news that it's made a deal to buy Acreage Holdings. Yahoo Finance's Zack Guzman and Kristin Myers are joined by Lauren Smith Brody, 'The Fifth Trimester' author and founder, to discuss.

  • Here's Why Blackstone Shares Jumped on Thursday
    Motley Fool

    Here's Why Blackstone Shares Jumped on Thursday

    Shares of Blackstone Group (NYSE: BX) climbed nearly 7% on Thursday morning after the alternative asset manager reported first-quarter earnings that blew past expectations and announced plans to convert to a corporation from a partnership. Blackstone, before markets opened, said it had earned $0.71 per share in the first quarter, easily surpassing the consensus estimate for $0.53 per share in earnings. The partnership structure has prevented some classes of investors, namely pension funds and other tax-exempt institutions, from buying shares of Blackstone, and has made the company ineligible for inclusion on certain indexes.

  • Is Aphria a Buy on the Dip?
    Motley Fool

    Is Aphria a Buy on the Dip?

    Shares of Aphria (NYSE: APHA) have tumbled about 16% since the company reported earnings results for its fiscal third quarter. This was the first full quarter since the company and its peers began selling adult-use recreational marijuana in Canada, and investors enthusiastic about the future are wondering if the market has overreacted and created a bargain opportunity. Let's take a closer look at the road ahead of Aphria to see if this troubled marijuana stock is a buy right now.

  • How Tesla Stock Is Trading ahead of Its Q1 2019 Results
    Market Realist

    How Tesla Stock Is Trading ahead of Its Q1 2019 Results

    Could Tesla's Q1 2019 Earnings Help Its Stock Recover? Tesla's first-quarter earnings Tesla (TSLA) is scheduled to release its first-quarter earnings results after the market closes on April 24.

  • IBM Senior VP: Why Red Hat's future is so bright

    IBM Senior VP: Why Red Hat's future is so bright

    Jim Cramer chats with IBM Senior Vice President of Global Markets Martin Schroeter to hear what plans the company has once its acquisition of Red Hat closes.

  • Boeing 'shielded' from 737 Max order cancellations

    Boeing 'shielded' from 737 Max order cancellations

    Don't expect Boeing Co. to face a slew of order cancellations following the 737 Max debacle. Airlines, Boeing's (BA) main customers, are hungry for fuel-efficient single-aisle aircraft such as the Max, and there's a long backlog for the jet's closest competitor, Airbus SE' (FR:AIR) A320neo, analysts at Oxford Economics said in a note Thursday. “That will shield Boeing from a mass cancellation of orders,” the analysts said.

  • 10 Reasons to Buy Twilio Stock and Never Sell
    Motley Fool

    10 Reasons to Buy Twilio Stock and Never Sell

    The number of active customers using Twilio's platform to communicate with their clients has increased four-fold in four years. Concurrently, base revenue -- which excludes low-margin professional services and customers that don't sign long-term contracts -- has exploded. All of this is to say: Twilio has been an extremely popular option over the past five years.

  • Why Nintendo Stock Popped Today
    Motley Fool

    Why Nintendo Stock Popped Today

    What happened Shares of Nintendo (NASDAQOTH: NTDOY) were up 13.6% as of 1:30 p.m. EDT Thursday after news emerged that the company's Switch gaming console will soon begin selling in China. But Nintendo won't be selling the devices directly.

  • Investors Who Bought Brookdale Senior Living (NYSE:BKD) Shares Five Years Ago Are Now Down 79%
    Simply Wall St.

    Investors Who Bought Brookdale Senior Living (NYSE:BKD) Shares Five Years Ago Are Now Down 79%

    Because Brookdale Senior Living is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

  • Why Mustang Bio Stock Is On Fire Today
    Motley Fool

    Why Mustang Bio Stock Is On Fire Today

    Mustang's shares are blasting off in response to the news that an experimental gene therapy, MB-107, for "bubble boy" disease -- also known as X-linked severe combined immunodeficiency, or XSCID for short -- reportedly cured eight boys with the deadly condition. Equally critical, Mustang said that the boys are showing no signs of unintended side effects from the therapy -- an issue that has derailed prior gene therapies for XSCID. Mustang licensed MB-107 from St. Jude Children's Research Hospital.

  • Harry Boxer: Two marijuana stocks are among charts worth watching

    Harry Boxer: Two marijuana stocks are among charts worth watching

    Marijuana stocks are among our top charts to watch today. Bank of America Merrill Lynch named the company as one of three marijuana stocks to buy. The stock, after sharp year-to-date gains, has been consolidating in recent weeks, but may be on the verge of its next leg up with cannabis stocks in general.

  • TriCo (TCBK) to Report Q1 Results: Wall Street Expects Earnings Growth

    TriCo (TCBK) to Report Q1 Results: Wall Street Expects Earnings Growth

    The market expects TriCo (TCBK) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2019. The stock might move higher if these key numbers top expectations in the upcoming earnings report. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

  • Cover story: Joseph Kim's art of the bio-deal
    American City Business Journals

    Cover story: Joseph Kim's art of the bio-deal

    While many biopharmaceutical companies have partnerships or collaborations with one or two larger companies, Inovio Pharmaceuticals has product development deals in place with more than a half dozen pharmaceutical and biotech firms and research organizations inside and outside the United States.  Inovio is in that position largely because it is developing a technology platform with two parts that can be applied to a variety of medical conditions. The second part is the system for delivering the therapy through the skin or into muscle tissues using brief and low voltage electronic pulses.   That standing, said Inovio co-founder and CEO J. Joseph Kim, gives the Plymouth Meeting-based company different aspirations than other development-stage drug developers.

  • Cobalt 27 Capital (CVE:KBLT) Shareholders Booked A 88% Gain In The Last Three Years
    Simply Wall St.

    Cobalt 27 Capital (CVE:KBLT) Shareholders Booked A 88% Gain In The Last Three Years

    For example, the Cobalt 27 Capital Corp. (CVE:KBLT) share price is up 88% in the last three years, clearly besting than the market return of around 15% (not including dividends). To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

  • Here's Why Shares of Uxin Climbed Higher on Thursday
    Motley Fool

    Here's Why Shares of Uxin Climbed Higher on Thursday

    Chinese online used-car dealer Uxin's (NASDAQ: UXIN) volatile week continued on Thursday, with shares up more than 11% as the market continues to digest, and at least for now dismiss, a critical short-seller report that temporarily sent shares crashing. Shares of Uxin lost more than half of their value midday Tuesday after J Capital Research analyst Anne Stevenson-Yang issued a report claiming that Uxin has exaggerated the volume of auto sales it processes by as much as 40%, and that founder and CEO Kun Dai was making false statements about the business' strength while taking cash out of the business. The response helped Uxin shares to recover much of what they lost on Wednesday.

  • Is Core Laboratories N.V. (NYSE:CLB) A High Quality Stock To Own?
    Simply Wall St.

    Is Core Laboratories N.V. (NYSE:CLB) A High Quality Stock To Own?

    This article is for those who would like to learn about Return On Equity (ROE). Core Laboratories has a ROE of 50%, based on the last twelve months. Another way to think of that is that for every $1 worth of equity in the company, it was able to earn $0.50.

  • Snap Stock Downgraded Twice in 1 Day: What You Need to Know
    Motley Fool

    Snap Stock Downgraded Twice in 1 Day: What You Need to Know

    Wedbush thinks this expectation is already factored into Snap's higher share price, and therefore rates the stock only neutral, with a $12.25 price target. Downgrading Snap stock, part deux Vertical Group is even more pessimistic, observing in a note covered by StreetInsider.com (subscription required) that Snap is experiencing "stagnant" return on its investments, and cutting spending (because without returns, what's the point? in order to conserve cash.

  • Why Check Point Software Stock Dropped 8% Today
    Motley Fool

    Why Check Point Software Stock Dropped 8% Today

    Shares of IT security specialist Check Point Software Technologies (NASDAQ: CHKP) plunged more than 11% in early trading on the Nasdaq today before retracing to about an 8.2% loss as of 12:40 p.m. EDT. Check Point reported its fiscal first-quarter 2019 earnings this morning, but earnings weren't the problem this time -- guidance was. An earnings beat could have sent Check Point stock up today.